13N-Ammonia total solution for cardiac PET imaging
Full independenceAKURACY® enables cardiac imaging centers to achieve full independence from external radiotracer suppliers by providing on-demand, in-house production capabilities.
Patient-FriendlyThe diagnostic process is a better experience for patients than the conventional imaging process, as the patient workflow is faster and much less radiation exposure (max. 2 mSv).
Ease of useThe entire process is controlled by high-level software with an intuitive interface that can be operated by qualified personnel. From tracer production to dose availability, on demand and tailored to your schedule.
Low opexFully automated production results in higher daily patient throughput, reducing your operating expenses and saving your time.
Imagine you could give your patients a faster, more precise diagnosis of their cardiac condition. Suppose you could use advanced PET imaging to identify coronary artery disease with greater accuracy. And capitalize on 13N-NH3-based PET imaging to make the whole diagnostic process more patient-friendly. Think of all the advantages... rapid throughput, lower radiation burden and a wealth of clinical information.
IBA makes this possible. We draw on our vast experience developing and integrating versatile cyclotrons into total solutions like Akuracy® to enrich every single step of the cardiac PET diagnostic process: from setting up the cyclotron at your imaging facility and producing the 13N-Ammonia (13N-NH3) tracer to training your people in typical daily use and maintenance.
Nuclear Cardiologist, The Netherlands
The AKURACY® will provide imagers with all the benefits of 13N-NH3 cardiac PET imaging in a very simple easy to use complete package. This will increase the accessibility of cardiac PET for general use.
Cardiac PET (positron emission tomography) imaging is a fast-growing clinical tool endorsed by well recognized clinical guidelines and has demonstrated its high accuracy and precision.
13N-Ammonia is an effective diagnostic tool that improves patient management by accurately detecting coronary artery disease (CAD) due to its short positron range, high sensitivity,...
